Baxter Ventures and MVM Life Science Partners have co-led a round that doubled the total equity funding raised by the patient monitoring device developer since 2011.

Novartis Venture Fund and Hikma Ventures have co-led a series A round for online prescription management platform Lemonaid Health, taking its total funding to near $20m.

The Purdue Foundry Investment Fund reinvested in a $30m round for Symic that will support a phase 3 trial for a compound intended to improve vein graft surgery.

Linear Diagnostics has raised $390,000 from investors including the University of Birmingham Spinout Investment Fund.

Lilly Ventures and Mitsui Global Investment reinvested in a $30m round for Symic that will support a phase 3 trial for a compound intended to improve vein graft surgery.

Bioverativ could end up paying $825m for rare disease drug developer True North, which had raised $142m from backers including GlaxoSmithKline, Biogen Idec, Baxter and Baxalta.

Investment banking firm RM Global has raised $30m for the first close for a fund that will back startups developed by Johnson & Johnson and Takeda-backed incubator FutuRx.

Bupa's Blue Table accelerator is one of a range of corporate startup initiatives to be launched in the past month, including those by Rabobank, Bosch, HPE and Sunway.

WuXi PharmaTech's corporate venturing arm will merge with VC firm Frontline BioVentures to create an investment firm with $800m of assets under management.